GamaMabs Pharma raised €15M in a Series B round in Dec 2015. The company is based in Toulouse, France. Investors in the round: Alto Invest, Edmond de Rothschild Venture Capital, iXO Private Equity. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €15M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
